5.5100.90% ( -0.050 )
Delay Closed: Nov 16, 16:08:11Valuation
Current ValuationThe current P/E ratio is 37.42, within the reasonable range, cheaper than 28.35% of the time in the past 1 years, and the industry ranks 30/53, the industry Median 6.94.
37.42xP/E
HK$5.51Stock price
HK$0.15Earnings per share
37.42xP/E
Stock priceHK$5.51Earnings per shareHK$0.15
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 34.75x
- Typical range
- 29.04x–38.10x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.94x
010203040
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.94x
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
01276HKHENGRUI PHARMA | 31.40x | 22.32% | HK$324.96B |
01177HKSBP GROUP | 37.42x | 112.16% | HK$102.94B |
06821HKAsymchem | 30.01x | 27.07% | HK$41.41B |
02206HKNEAUTUS | 34.60x | -- | HK$4.73B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
